Heron Therapeutics, Inc.
NasdaqCM:HRTX
$ 2.77
$0.00 (0.00%)
$ 2.77
$0.00 (0.00%)
End-of-day quote: 05/10/2024

HRTX - Heron Therapeutics Stock Prediction 2025 - 2030

20 years of reliable Heron Therapeutics stock forecast. The Wall Street analysts predict Buy for HRTX. See at a glance whether NasdaqCM:HRTX will rise in the future.

$0.00
Forecast 2023
$3.30
Forecast 2025
$5.61
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$3.30
Forecast 2030
$5.61
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.73
Price-to-book Ratio
N/A
Market Cap
0.44B
TEV
0.55 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$5.63

Heron Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Heron Therapeutics Stock Forecast 2023

$6.50

In the last five quarters, Heron Therapeutics’s Price Target has fallen from $8.41 to $5.63 - a -33.06% decrease. Two analysts predict that Heron Therapeutics’s share price will increase in the coming year, reaching $6.50. This would represent an increase of 15.45%.

134.66%
134.66
Last update: 05/13/2024

Highest Price Target $9.00

Average Price Target $6.50

Lowest Price Target $5.00

Heron Therapeutics Stock Forecast 2025

Stock Prediction for the Price of One Heron Therapeutics Share in Jan 2025.

In Jan 2025 analysts predict a share price of $2.99. An increase of 8.08% compared to today's share price.

Stock Prediction for the Price of One Heron Therapeutics Share in Feb 2025.

In Feb 2025 analysts predict a share price of $3.02. An increase of 9.08% compared to today's share price.

Stock Prediction for the Price of One Heron Therapeutics Share in Mar 2025.

In Mar 2025 analysts predict a share price of $3.05. An increase of 10.08% compared to today's share price.

Stock Prediction for the Price of One Heron Therapeutics Share in Apr 2025.

In Apr 2025 analysts predict a share price of $3.08. An increase of 11.08% compared to today's share price.

Stock Prediction for the Price of One Heron Therapeutics Share in May 2025.

In May 2025 analysts predict a share price of $3.10. An increase of 12.08% compared to today's share price.

Stock Prediction for the Price of One Heron Therapeutics Share in Jun 2025.

In Jun 2025 analysts predict a share price of $3.13. An increase of 13.07% compared to today's share price.

Stock Prediction for the Price of One Heron Therapeutics Share in Jul 2025.

In Jul 2025 analysts predict a share price of $3.16. An increase of 14.07% compared to today's share price.

Stock Prediction for the Price of One Heron Therapeutics Share in Aug 2025.

In Aug 2025 analysts predict a share price of $3.19. An increase of 15.07% compared to today's share price.

Stock Prediction for the Price of One Heron Therapeutics Share in Sep 2025.

In Sep 2025 analysts predict a share price of $3.22. An increase of 16.07% compared to today's share price.

Stock Prediction for the Price of One Heron Therapeutics Share in Oct 2025.

In Oct 2025 analysts predict a share price of $3.24. An increase of 17.07% compared to today's share price.

Stock Prediction for the Price of One Heron Therapeutics Share in Nov 2025.

In Nov 2025 analysts predict a share price of $3.27. An increase of 18.07% compared to today's share price.

Stock Prediction for the Price of One Heron Therapeutics Share in Dec 2025.

In Dec 2025 analysts predict a share price of $3.30. An increase of 19.07% compared to today's share price.

Heron Therapeutics Stock Predictions 2030

Heron Therapeutics Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $5.09. An increase of 83.69% compared to the previous month's estimate.

Heron Therapeutics Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $5.14. An increase of 85.38% compared to the previous month's estimate.

Heron Therapeutics Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $5.18. An increase of 87.08% compared to the previous month's estimate.

Heron Therapeutics Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $5.23. An increase of 88.78% compared to the previous month's estimate.

Heron Therapeutics Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $5.28. An increase of 90.48% compared to the previous month's estimate.

Heron Therapeutics Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $5.32. An increase of 92.17% compared to the previous month's estimate.

Heron Therapeutics Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $5.37. An increase of 93.87% compared to the previous month's estimate.

Heron Therapeutics Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $5.42. An increase of 95.57% compared to the previous month's estimate.

Heron Therapeutics Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $5.46. An increase of 97.26% compared to the previous month's estimate.

Heron Therapeutics Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $5.51. An increase of 98.96% compared to the previous month's estimate.

Heron Therapeutics Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $5.56. An increase of 100.66% compared to the previous month's estimate.

Heron Therapeutics Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $5.61. An increase of 102.35% compared to the previous month's estimate.

P/E
0.00
Beta
1.73
Price-to-book Ratio
N/A
Market Cap
0.44B
TEV
0.55 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$5.63

Heron Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Heron Therapeutics, Inc.?

The following analysts have recently covered Heron Therapeutics:

Jefferies LLC
Marktfeld
Needham & Company
Northland Capital Markets
Capital One Securities, Inc.
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Heron Therapeutics, Inc.?

The following sell-side analysts have recently covered Heron Therapeutics:

Shi, Dingding
Paraskevopoulos, Michail
Belanger, Serge D.
Byrnes, Carl Edward
Chiang, Timothy
(This information refers to the last 90 days.)